¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"phase variation"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
advanced sleep phase syndrome
ÀüÁø¼ö¸éÀ§»óÁõÈıº
anal-sadistic phase
Ç×¹®°¡Çбâ
bulk phase model
µ¢¾î¸®À§»ó¸ðÇü
circadian-phase intervention
ÇÏ·çÁÖ±âÀ§»óÁßÀç
colostral phase
ÃÊÀ¯±â, ùÁ¥¼·Ãë±â
compression phase
¾ÐÃà»ó
delayed sleep phase
¼ö¸éÀ§»óÁö¿¬
delayed sleep phase syndrome
¼ö¸éÀ§»óÁö¿¬ÁõÈıº
depressive phase
¿ì¿ï»ó
death phase
»ç¸ê±â
diastolic phase
È®Àå±â
disperse phase
ºÐ»ê±â
diurnal phase
ÁÖ°£»ó
expiratory phase
È£±â»ó
expiratory phase time
³¯¼û½Ã°£, È£±â½Ã°£
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
14
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
phase
»ó, ±â, À§»ó
acceleration phase
ÃËÁø±â, °¡¼Ó±â
active phase
Ȱ¼º±â
latent phase
ÀáÀç±â , Àẹ±â
plateau phase
ÆíÆò±â, °íÁ¶±â
relaxation phase
À̿ϱâ, À̿ϻó
resolution phase
ÇØ¼Ò±â
resting phase
È޽ıâ
solid phase
°íü»ó
stance phase
µðµõ±â, ÀÔ°¢±â
swing phase
Èçµê±â, À¯°¢±â
synaptic phase
¿¬Á¢±â
expiratory phase time
³¯¼û½Ã°£, È£±â½Ã°£
inspiratory phase time
µé¼û½Ã°£, Èí±â½Ã°£
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acceleration phase
ÃËÁø±â, °¡¼Ó±â
acute phase reactant
±Þ¼º±â¹ÝÀÀ¹°Áú
acute phase reaction
±Þ¼º±â¹ÝÀÀ
acute phase serum
±Þ¼º±âÇ÷û
advanced sleep phase syndrome
ÀüÁø¼ö¸éÀ§»óÁõÈıº
anal-sadistic phase
Ç×¹®°¡Çбâ
phase advance
À§»óÀüÁø
phase artifact
À§»óÀΰø¹°
phase axis
ˤȗ̈
phase shift artifact
À§»óº¯À§Àΰø¹°
phase wraparound artifact
À§»óÆ÷ÀåÀΰø¹°
bulk phase model
µ¢¾î¸®À§»ó¸ðÇü
circadian-phase intervention
ÀÏÁÖ±âÀ§»óÁßÀç
colostral phase
ùÁ¥±â, ÃÊÀ¯±â
compression phase
¾ÐÃà»ó
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
physiologic variation
»ý¸®Àû º¯µ¿<º¯ÀÌ>
range of variation
º¯ÀÌÆø.
3D phase contrast angiography
3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
DNA synthetic phase
DNA ÇÕ¼º±â
Go phase
Go±â
accelerated death phase
°¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
acceleration phase
ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
acute phase protein
±Þ¼ºº´±â´Ü¹éÁú
acute phase reactant
±Þ¼º±â ÀÛ¿ë¹°Áú
acute phase reaction
±Þ¼º±â¹ÝÀÀ(¡Ñ¢Úãëë)
acute phase reactive protein
±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
acute phase serum
±Þ¼ºº´±âÇ÷û
acute phase substances
±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
advanced sleep phase syndrome
ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
anal-sadistic phase
Ç×¹®-°¡ÇÐ(½Ã)±â
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
double variation
ÀÌÁߺ¯µ¿(ÊÙËÒËÄ).
erythrocyte variation
ÀûÇ÷±¸º¯ÀÌ
ethnic variation
ÀÎÁ¾Àû º¯ÀÌ
genetic variation
À¯Àüº¯ÀÌ(¡Ü¨ì¶).
genetic variation
À¯ÀüÀûº¯ÀÌ
genotypic variation
À¯ÀüÀÚÇüº¯ÀÌ.
genotypic variation
À¯ÀüÀÚÇüº¯µ¿.
hereditable variation
À¯Àü¼ºº¯ÀÌ
heritable variation
À¯Àü¼º º¯ÀÌ.
host controlled variation
¼÷ÁÖÀÇÁ¸(±ÔÁ¦)º¯ÀÌ.
inborn variation
¼±Ãµ¼º º¯ÀÌ.
individual variation
°³Ã¼º¯ÀÌ.
induced variation
À¯µµº¯ÀÌ.
interindividual variation
°³Àΰ£º¯ÀÌ<--º¯µ¿>
intraindividual variation
°³Àγ»º¯ÀÌ<--º¯µ¿>
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½